Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm

NEW YORK, June 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) breached their fiduciary duties to shareholders. 

Read more at prnewswire.com